A disease affecting the kidneys.
Urinary system disease that is located in the kidney.
1Introduction: Chronic kidney disease is now regarded as amajor public health concern.
2Evidence for risk factors to identify patients with kidney disease is limited.
3Context: Hyperuricemia is an independent risk factor for progression of kidney disease.
4Patients: 1628 patients with chronic kidney disease participating in the MDRD Study.
5Summary: Transplant recipients are a unique group of chronic kidney disease patients.
6Aging-associated kidney disease is usually considered a degenerative process associated with aging.
7The drugs are also used to treat anemia in kidney disease patients.
8The trial enrolled 121 patients with moderate to severe chronic kidney disease.
9If levels are high, the patient is likely to have kidney disease.
10The number of eGFR measurements to detect kidney disease can be reduced.
11These factors increase inflammation, oxidative stress, and progression of chronic kidney disease.
12Amgen also markets another ESA drug called Epogen for kidney disease patients.
13Improvements in care of individuals with kidney disease could reduce these costs.
14Oxidative stress is acknowledged to play a role in kidney disease progression.
15The polycystic kidney disease is a hereditary malformation seldom described in Africa.
16Aranesp is approved to treat anemia associated with chemotherapy and kidney disease.
Translations for kidney disease